- Home
- KIM vs ICLR Comparison
KIM vs ICLR Comparison
Compare KIM & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$20.15
HOLD
Current Price
$186.40
Company Overview
Basic Information| Metric | KIM | ICLR |
|---|---|---|
| Founded | 1958 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 14.3B |
| IPO Year | 1991 | 1998 |
Fundamental Metrics
Financial Performance| Metric | KIM | ICLR |
|---|---|---|
| Price | $20.15 | $186.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | $24.45 | ★ $201.23 |
| AVG Volume (30 Days) | ★ 4.6M | 1.0M |
| Earning Date | 10-30-2025 | 10-22-2025 |
| Dividend Yield | ★ 5.16% | N/A |
| EPS Growth | ★ 57.13 | N/A |
| EPS | 0.83 | ★ 7.47 |
| Revenue | $2,123,057,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $5.64 | N/A |
| Revenue Next Year | $3.02 | $0.76 |
| P/E Ratio | ★ $24.24 | $24.96 |
| Revenue Growth | ★ 8.14 | N/A |
| 52 Week Low | $17.93 | $125.10 |
| 52 Week High | $25.06 | $228.29 |
Technical Indicators
Market Signals| Indicator | KIM | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 43.69 | 59.73 |
| Support Level | $19.76 | $178.80 |
| Resistance Level | $20.47 | $188.99 |
| Average True Range (ATR) | 0.27 | 7.59 |
| MACD | 0.01 | 1.34 |
| Stochastic Oscillator | 36.62 | 83.07 |
Price Performance
Historical Comparison KIM
ICLR
About KIM Kimco Realty Corporation (HC)
One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 567 shopping centers throughout major markets in the US, representing roughly 101 million square feet.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.